Feed / Theme
Confirmed

Cancer and Nicotine Therapies

3 names are moving together; 100% are participating in the current session.

2 observed Confirmed episodes

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
DCTHDelcath Systems, Inc.Healthcare+1.8%1/5 observed active sessions
NVCRNovoCure LimitedHealthcare-3.4%3/5 observed active sessions
ACHVAchieve Life Sciences, Inc.Healthcare+3.4%4/5 observed active sessions

Why we believe this

Cohort

3 names

Participation

100% this session

Observed history

6 daily builds

This identity theme becomes less useful if activity narrows to one or two names instead of remaining broad across the cohort.

Connected, outside the group

ZLAB

NVCRpartner · Current intraday read unavailable

Filing receipt · ZLAB / NVCR

In 2018, we granted Zai Lab (Shanghai) Co., Ltd.

NVCR · partner
CADL

NVCRtext peer · Current intraday read unavailable

No filing excerpt is available for this relationship.

MRK

NVCRpartner · Current intraday read unavailable

Filing receipt · MRK / NVCR

KEYNOTE D58 was designed and is being conducted as part of a clinical collaboration between Novocure and MSD, a tradename of Merck & Co., Inc.

NVCR · partner
REPL

NVCRtext peer · Current intraday read unavailable

No filing excerpt is available for this relationship.

IOVA

NVCRtext peer · Current intraday read unavailable

No filing excerpt is available for this relationship.

History

2026-07-07 → 2026-07-104 observed active sessions · 0% of active names held across the episode
2026-07-021 observed active session · 100% of active names held across the episode